INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Company

PMV Pharmaceuticals, Inc.

Filed

May 7, 2021

Period of Report

April 28, 2021

Accession Number

0001062993-21-004263